Navigation Links
Novagali Pharma Announces the Launch of Cationorm(R)
Date:4/9/2008

The Innovative Cationic Emulsion for the Treatment of Dry Eye Symptoms

An Optimal Solution for Patients

The First Product Developed From its Pipeline to be Marketed

EVRY, France, April 9 /PRNewswire/ -- Novagali Pharma, an ophthalmic specialty pharmaceutical company announces the commercial launch in France of its first product Cationorm(R). This cationic emulsion is an innovative approach to treat dry eye symptoms. It has been developed on the basis of Novagali Pharma patented technology platform Novasorb(R).

Dry eye syndrome is the second cause of consultation in ophthalmology. It concerns over 100 million people in the world and 14% of the adults of more than 40 years. Due to a chronic lack of lubrication and moisture in the eye, its consequences range from irritation to ocular inflammation of the conjunctiva and corneal tissues of the eyes. People with dry eye have sandy-gritty irritation or burning in their eyes. In most severe cases, corneal lesions may lead to vision loss. Specific factors such as ageing populations, pollution, air conditioning, extended use of computers, contribute to an increase in the prevalence of the syndrome and in opportunities for the development of more efficient products.

Cationorm(R) brings a true innovation to the patients suffering from dry eye symptoms. The cationic emulsion reproduces the tear mechanisms of action to act on the different levels of the tear film. Cationorm(R) uniquely combines lubricating and hydrating properties, optimal spreading on the surface of the eye, replenishment of the tear film lipid layer and prevention of tear evaporation. The results of clinical study have clearly demonstrated Cationorm(R) advantages for patients: tolerance, long-lasting relief and optimal comfort.

These advantages are based on Novasorb(R), the proprietary cationic emulsion technology platform of Novagali Pharma. Novasorb(R), is designed to improve topical administ
'/>"/>

SOURCE Novagali Pharma
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
3. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
4. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
5. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... sound-processing part of the mouse brain in a way ... in view. Their imaging technique allows zooming in and ... it enabled the team to watch brain cells light ... which represent a step toward better understanding how our ... journal Neuron . , In the past, researchers ...
(Date:7/31/2014)... 2014 According to a new ... Market - Global Industry Analysis, Size, Share, Growth, Trends ... at USD 88.5 million in 2011, which is expected ... a CAGR of 53.8% from 2013 to 2023. ... http://www.transparencymarketresearch.com/quantum-dots.html Increasing demand for energy efficient ...
(Date:7/31/2014)... North Shore Towers, a luxury co-op community based just ... of the nation’s leading combined heating and power (CHP) systems ... CHP system. The original CHP system had been maintained since ... life of the plant, GI Energy was contracted to replace ... equipment, while maintaining continuous operation of the entire complex. ...
(Date:7/31/2014)... Francisco, California (PRWEB) July 31, 2014 ... systems that inform therapeutic decision-making in oncology, today announced ... August 14, 2014 to discuss the Company's financial results ... provide an update about the business in the current ... audio call beginning on Thursday, August 14, 2014, at ...
Breaking Biology Technology:New mapping approach lets scientists zoom in and out as the brain processes sound 2Global Quantum Dots Market is Expected to Reach USD 8,246.8 Million in 2023: Transparency Market Research 2Global Quantum Dots Market is Expected to Reach USD 8,246.8 Million in 2023: Transparency Market Research 3Global Quantum Dots Market is Expected to Reach USD 8,246.8 Million in 2023: Transparency Market Research 4North Shore Towers Partners with GI Energy to Install Turnkey Natural Gas-Fired Combined Heat and Power Plant 2CollabRx, Inc. Schedules First Quarter Fiscal Year 2015 Financial Conference Call and Business Update 2
... Cord Blood America, Inc . (OTC BB: CBAI, CBAID) announced ... 80 percent of its shareholders voting in a recent proxy vote, ... The one for one hundred reverse split reduces the ... A "D" will be placed on the ticker symbol ...
... BALTIMORE, May 6, 2011 Stenting is safe and ... venous stenosis in patients with deep vein thrombosis (DVT), ... Late-Breaking Clinical Trial at the Society for Cardiovascular Angiography ... EVISTA-DVT focused on patients with blocked veins ...
... Halozyme Therapeutics, Inc. (Nasdaq: HALO ), ... extracellular matrix for the diabetes, cancer, dermatology ... the first quarter 2011. (Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO ... duration of action observed in our first ultrafast insulin ...
Cached Biology Technology:Study Shows Stents Are Superior to Balloons Alone for Patients With Deep Venous Thrombosis 2Halozyme Therapeutics Reports First Quarter 2011 Financial Results 2Halozyme Therapeutics Reports First Quarter 2011 Financial Results 3Halozyme Therapeutics Reports First Quarter 2011 Financial Results 4Halozyme Therapeutics Reports First Quarter 2011 Financial Results 5Halozyme Therapeutics Reports First Quarter 2011 Financial Results 6
(Date:7/31/2014)... BOZEMAN, Mont. In the same week that the ... dangers of skin cancer, researchers at Montana State University ... the genetic code in every cell responds ... advance fundamental understanding of DNA damage by the UV ... skin cancer, aging and some degenerative eye diseases. ...
(Date:7/31/2014)... familiar with Hibiscus flowers- they are an iconic ... commonly planted in the landscape. Some, like Hawaii,s ... species. , Only a relatively few botanists and ... equally beautiful and intriguing related group of plants ... Hibiscus". , Brother of Hibiscus species are in ...
(Date:7/31/2014)... SPRINGS, Florida , July 31, 2014 ... to develop unique and innovative smart technologies; companies turn ... (NASDAQ: EBAY ), Amazon.com Inc. (NASDAQ: ... ), Google Inc. (NASDAQ: GOOG ) and ... biometric authentication company focused on the growing m-commerce market, ...
Breaking Biology News(10 mins):New paper describes how DNA avoids damage from UV light 2New paper describes how DNA avoids damage from UV light 3Brother of Hibiscus is found alive and well on Maui 2Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 2Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 3Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 4Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 5Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 6
... the color of ocean waters could have a drastic effect on ... such a change in one region of the North Pacific, the ... be a big drop for a region that accounts for more ... that the formation of typhoons as hurricanes are known in ...
... 13, 2010 -- Ben-Gurion University of the Negev,s (BGU) Dr. ... and Environmental Research Center (BERC) in Nablus received a significant ... the Middle East. This study brings together Israelis and Palestinians ... of Nablus over a five-year period. ...
... RICHLAND, Washington -- A little wax and soap can ... to a study in August 11 issue of ... developers to explore lower-priced alternatives to the lithium ion-metal ... a medium in which to grow good electrode materials," ...
Cached Biology News:Ocean's color affects hurricane paths 2Ocean's color affects hurricane paths 3Wax, soap clean up obstacles to better batteries 2Wax, soap clean up obstacles to better batteries 3Wax, soap clean up obstacles to better batteries 4
...
Mouse monoclonal [2G1] to Vancomycin ( Abpromise for all tested applications)....
Rab1A...
... ( Abpromise for all tested ... Synthetic peptide: DWLCL AFVE SKFNISKINE NADGSFDYGL ... amino acids 46-100 of Human LYZL6 ... 57151 Swiss ...
Biology Products: